NAT14 Antikörper (AA 1-57)
Quick Overview for NAT14 Antikörper (AA 1-57) (ABIN2585632)
Target
Alle NAT14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-57
-
Spezifität
- Human NAT14
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Partial recombinant (aa1-57) from human KLP1 (NP_065111) with GST tag. MW of the GST tag alone is 26 KDa.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Andere Bezeichnung
- NAT14
-
Hintergrund
-
Name/Gene ID: NAT14
Synonyms: NAT14, KLP1, N-acetyltransferase 14 -
Gen-ID
- 57106
-
NCBI Accession
- NP_065111
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-